SGH
SCLN

Schonfeld Group Holdings’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Schonfeld Group Holdings’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$462K Buy
+50,200
New +$420K 0.29% 102
2015
Q1 		– Sell
-18,800
Closed -$165K – 33
2014
Q4 		$165K Sell
18,800
-10,000
-35% -$80.9K 2.21% 16
2014
Q3 		$198K Buy
28,800
+9,300
+48% +$55.7K 0.59% 25
2014
Q2 		$103K Buy
+19,500
New +$94.9K 0.35% 20

Other funds holding SCLN

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sensato Investors San Francisco, California $122M AUM 5.69% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Schonfeld Group Holdings's SCLN Position: Q4 2015 in Review

Schonfeld Group Holdings opened a new position in Sciclone Pharmaceuticals Inc (SCLN) in Q4 2015: 50,200 shares worth $462K. The stake represents 0.29% of the portfolio and ranks #102 among its holdings. This is a return to the name: Schonfeld Group Holdings previously reported a position in SCLN as recently as Q4 2014.

Schonfeld Group Holdings first reported a position in SCLN in Q2 2014 and has held it in 4 quarters since. 133 funds tracked by Wall St. Rank hold SCLN as of Q4 2015.

  • Schonfeld Group Holdings held 50,200 shares of Sciclone Pharmaceuticals Inc worth $462K as of Q4 2015.
  • Sciclone Pharmaceuticals Inc was a new Schonfeld Group Holdings position in Q4 2015.
  • Sciclone Pharmaceuticals Inc made up 0.29% of Schonfeld Group Holdings's portfolio in Q4 2015, its #102 holding.
  • Schonfeld Group Holdings first reported a position in Sciclone Pharmaceuticals Inc in Q2 2014 and has held it in 4 quarters since.
  • 133 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2015.

Based on Schonfeld Group Holdings's 13F filing for Q4 2015, filed 12 Feb 2016.